Your browser doesn't support javascript.
Physician visits and medication prescriptions for major chronic diseases during the COVID-19 pandemic in Japan: retrospective cohort study.
Osawa, Itsuki; Goto, Tadahiro; Asami, Yuko; Itoh, Noriharu; Kaga, Yasuyuki; Yamamoto, Yuji; Tsugawa, Yusuke.
  • Osawa I; Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan ioosawa-tky@umin.ac.jp.
  • Goto T; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Asami Y; TXP Medical Co. Ltd, Bunkyo-ku, Tokyo, Japan.
  • Itoh N; Viatris Pharmaceuticals Japan Inc, Shibuya-ku, Tokyo, Japan.
  • Kaga Y; Viatris Pharmaceuticals Japan Inc, Shibuya-ku, Tokyo, Japan.
  • Yamamoto Y; EPS Corporation, Shinjuku-ku, Tokyo, Japan.
  • Tsugawa Y; MinaCare Co., Ltd, Chiyoda-ku, Tokyo, Japan.
BMJ Open ; 11(7): e050938, 2021 07 23.
Article in English | MEDLINE | ID: covidwho-1322826
ABSTRACT

OBJECTIVES:

There have been concerns that patients with chronic conditions may be avoiding in-person physician visits due to fear of COVID-19, leading to lower quality of care. We aimed to investigate changes in physician visits and medication prescriptions for chronic diseases before and during the COVID-19 pandemic at the population level.

DESIGN:

Retrospective cohort study.

SETTING:

Nationwide claims data in Japan, 2018-2020.

PARTICIPANTS:

Working-age population (aged 18-74 years) who visited physicians and received any prescriptions for major chronic diseases (hypertension, diabetes and dyslipidaemia) before the pandemic. OUTCOME

MEASURES:

The outcomes were the monthly number of physician visits, the monthly proportion of physician visits and the monthly proportion of days covered by prescribed medication (PDC) during the pandemic (April-May 2020, as the first state of emergency over COVID-19 was declared on 7 April, and withdrawn nationally on 25 May).

RESULTS:

Among 10 346 patients who visited physicians for chronic diseases before the pandemic, we found a temporary decline in physician visits (mean number of visits was 1.9 in March vs 1.7 in April; p<0.001) and an increase in the proportion of patients who did not visit any physicians during the pandemic (15% in March vs 24% in April; p<0.001). Physician visits returned to the baseline in May (the mean number of visits 1.8, and the proportion of patients who did not visit any physicians 9%). We observed no clinically meaningful difference in PDC between before and during the pandemic (eg, 87% in March vs 87% in April; p=0.45). A temporary decline in physician visits was more salient in seven prefectures with a larger number of COVID-19 cases than in other areas.

CONCLUSIONS:

Although the number of physician visits declined right after the COVID-19 outbreak, it returned to the baseline one month later; patients were not skipping medications during the pandemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physicians / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-050938

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Physicians / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-050938